OLANIKE KATIBI: Open Payments
NPI 1063712081 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,202 in 37 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $1,303 · 2025 $1,202
Food & beverage: $1,103Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $453 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $319 |
| Supernus Pharmaceuticals, Inc. | 8 | $178 |
| Teva Pharmaceuticals USA, Inc. | 1 | $100 |
| Otsuka America Pharmaceutical, Inc. | 4 | $70 |
| Axsome Therapeutics, Inc. | 3 | $51 |
| Vanda Pharmaceuticals Inc. | 1 | $32 |
Products named: VRAYLAR, CAPLYTA, Qelbree, REXULTI, Auvelity, FANAPT.
Industry payments across TX — which companies pay providers there.
